HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness.

AbstractOBJECTIVE:
Narcolepsy is a rare disabling sleep disorder characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). Drugs such as pitolisant, which block histamine H3 autoreceptors, constitute a newly identified class of stimulants because they increase brain histamine and enhance wakefulness in animal and human adult narcolepsy.
METHODS:
We report our experience with the off-label use of pitolisant in 4 teenagers with narcolepsy/cataplexy with severe daytime sleepiness, refractory to available treatments (modafinil, methylphenidate, mazindol, sodium oxybate, and D-amphetamine).
RESULTS:
All teenagers developed their disease during childhood (11.3 ± 2.4 years; 50% boys) and were 17.3 ± 0.8 years old at the time of pitolisant therapy. Pitolisant treatment was increased from 10 to 30 mg (n = 1) and 40 mg (n = 3). The adapted Epworth Sleepiness Score decreased from 14.3 ± 1.1 to 9.5 ± 2.9 (P = 0.03) with pitolisant alone to 7 ± 3.4 when combined with mazindol (n = 1), methylphenidate (n = 1), or sodium oxybate plus modafinil (n = 1). Mean sleep onset latency increased from 31 ± 14 minutes to 36 ± 8 minutes (P = 0.21) on the maintenance of wakefulness test. The severity and frequency of cataplexy were slightly improved. Adverse effects were minor (insomnia, headache, hot flushes, leg pain, and hallucinations) and transitory, except for insomnia, which persisted in 2 teenagers. The benefit was maintained after a mean of 13 months.
CONCLUSIONS:
Pitolisant could constitute an acceptable alternative for the treatment of refractory sleepiness in teenagers with narcolepsy.
AuthorsClara Inocente, Isabelle Arnulf, Hélène Bastuji, Anne Thibault-Stoll, Aude Raoux, Rubens Reimão, Jian-Sheng Lin, Patricia Franco
JournalClinical neuropharmacology (Clin Neuropharmacol) 2012 Mar-Apr Vol. 35 Issue 2 Pg. 55-60 ISSN: 1537-162X [Electronic] United States
PMID22356925 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Central Nervous System Stimulants
  • Histamine Agonists
  • Piperidines
  • Receptors, Histamine H3
  • pitolisant
Topics
  • Adolescent
  • Cataplexy (drug therapy, physiopathology)
  • Central Nervous System Stimulants (pharmacology, therapeutic use)
  • Drug Inverse Agonism
  • Female
  • Follow-Up Studies
  • Histamine Agonists (pharmacology, therapeutic use)
  • Humans
  • Male
  • Narcolepsy (drug therapy, physiopathology)
  • Off-Label Use
  • Piperidines (pharmacology, therapeutic use)
  • Receptors, Histamine H3 (physiology)
  • Sleep Stages (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: